Breast Cancer Newswire

Vepdegestrant Outperforms Fulvestrant in PFS for ESR1-Mutant Advanced Breast Cancer

Results from the phase 3 VERITAC-2 trial (NCT05654623) shared at the 2025 ASCO Annual Meeting showed that vepdegestrant (ARV-471) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared …

Vepdegestrant Boosts Outcomes in ESR1-Mutant ER+/HER2– Advanced Breast Cancer

When compared with versus fulvestrant (Faslodex), vepdegestrant (ARV-471) treatment elicited a statistically significant and clinically meaningful improvement in survival without progression by blinded independent central review (BICR) in pretreated …

Full Arvinas, Pfizer data confirm potential, limits of ‘Protac’ drug in breast cancer

An experimental breast cancer drug from Arvinas and partner Pfizer modestly slowed disease progression in people whose tumors had changes to a specific gene, but did not provide a clear benefit to others who lacked that mutation. Full study results set to …

Real Housewives of Atlanta's Monyetta Shaw-Carter, 45, Reveals She Was Diagnosed with Breast Cancer (Exclusive)

NEED TO KNOW Monyetta Shaw-Carter was diagnosed with stage 1 invasive ductal carcinoma in November 2024 She had a lumpectomy in January followed by radiation, which she completed on May 2 The reality star is now feeling good and looking forward to her 45th …

STAT+: Combination treatment reduces risk of tumor progression in aggressive form of breast cancer, study shows

CHICAGO — A treatment that combines two different types of cancer-fighting medicines — Gilead Sciences’ Trodelvy with Merck’s Keytruda — reduced the risk of tumor progression by more than one-third in women with an aggressive form of breast cancer.  The …

2025 Wisconsin Breast Cancer Showhouse for a Cure in Milwaukee

The Wisconsin Breast Cancer Showhouse is celebrating 24 years of fighting breast and prostate cancer. Volunteer Chair Linda Short joined FOX6 WakeUp from North Lake Drive in Milwaukee to share more about their Showhouse for a Cure fundraiser that starts …

New three-drug combination 'could help women with aggressive breast cancer live longer'

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, a study has suggested. The trial, which included 325 patients from across 28 countries, showed the treatment more than doubled the time before the …

Gilead’s Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial

By Deena Beasley (Reuters) -Gilead Sciences’ Trodelvy in combination with Merck’s blockbuster immunotherapy Keytruda lowered the risk of an aggressive type of breast cancer worsening by 35% when used as an initial treatment, according to results of a large …

Pfizer-Arvinas breast cancer drug tops AstraZeneca’s in delaying progression

(Reuters) -An experimental treatment by Pfizer and Arvinas delayed progression of breast cancer by more than three months compared to AstraZeneca’s Faslodex in patients with a specific gene mutation, according to trial results announced on Saturday. The …

#ASCO25: Gilead, Merck reveal 'practice-changing' data for Trodelvy-Keytruda combo in aggressive breast cancer

#ASCO25: Arvinas, Pfizer's PROTAC in breast cancer no better than oral SERDs

Breast cancer screening bill backed by Duchow gets hearing

MADISON — A law that would require health insurance providers to cover diagnostic screenings for breast cancer in women with dense breast tissue had a public hearing Wednesday held by the Senate Committee on Health. Senate Bill 264, also known as " …

New breast cancer treatment prolongs survival, slows disease progression"

The new treatment regimen also delayed the need for subsequent chemotherapy by nearly two years, compared to patients in the control group. The study was funded by Roche and presented at the American Society of Clinical Oncology (ASCO) annual meeting in …

Three-drug therapy helps women with aggressive breast cancer live longer – trial

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests. The treatment could also delay the need for gruelling chemotherapy, according to a trial. Researchers are hopeful the combination …

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

Wisconsin Breast Cancer Showhouse

Analysis of Serum Soluble Endoglin and s-CD105 Levels in Relation to Postoperative Recurrence and Metastasis in Breast ...

Introduction Breast cancer is a major disease threatening women’s health worldwide. Current primary treatment methods include surgery, radiotherapy, chemotherapy, and endocrine therapy. Although its incidence and mortality rates have been somewhat …

Taunton breast cancer support group becomes charity

Heather Lamont, who founded Taunton Breast Friends two-and-a-half years ago, said the Charity Commission announcement on Thursday (May 29) “means the world” to her. It will enable the group to apply for more funding. “It’s absolutely superb. I couldn’t be …

Lobular breast cancer: What are the symptoms of second most common form of breast cancer

Lobular breast cancer, also known as invasive lobular carcinoma, is the second most common type of breast cancer found in women, but there is still little awareness around the disease - with many not having heard of it. According to Cancer Research UK, one …

Smile Scarsdale Family Dental Celebrates One Year of Smiles as Trusted Family Dentist in Scarsdale

SCARSDALE, NY, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- Smile Scarsdale Family Dental is proud to celebrate its one-year anniversary of delivering exceptional family dental care to the Scarsdale community and surrounding areas. Since …

Planet TV Studios Presents New Frontiers Episode 'Highlighting Emerging Technologies' Featuring Athena Clinic & Dr. ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON,, FL, UNITED STATES, May 31, 2025 …

Planet TV Studios Presents New Frontiers: Innovators Shaping Tomorrow. The content in the episode is a Planet TV Studios ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 …

'New Frontiers' Presents 4 Companies Revolutionizing: Brian Cancer Therapies, Robotic Surgery, Sustainable Solutions & ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 …

"New Frontiers" Presents Featuring Athena Clinic, MonDak Portables, LLC, NeOnc Technologies Holdings, Inc. & Hollobus ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 …

San Francisco Dental Implant Center Announces New Content on Convenient Dental Implant Locations in SF

San Francisco Dental Implant Center, a top dental implant center in San Francisco, California, is proud to announce new content focusing on convenient location. SAN FRANCISCO, CA, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- San Francisco …

Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell ...

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

The Good Feet Store Opens in Seabrook, NH to Help Local Residents and Workforce Live the Life They Love

The Leading Retailer of Premium, Personally-Fitted Arch Supports Expands with the Tenth Store in the Boston Area SEABROOK, NH, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- The Good Feet Store, recognized nationally as the market-leading …

Nurses for Natural Health Hosts Transformative Yoga Retreat for Nurses in France

PHOENIX , AZ, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- This July, Nurses for Natural Health invites nurses from around the world to join a one-of-a-kind restorative yoga retreat in the picturesque town of Luz-Saint-Sauveur. Designed to …

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in ...

Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic adenocarcinoma1 Post-hoc analysis of NAPOLI 3 study determined characteristics associated with long-term survival, with median …

Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec ...

L’essai de Phase III NAPOLI 3 est la plus grande étude interventionnelle réalisée à ce jour avec la plus longue période de suivi des patients avec un adénocarcinome pancréatique métastatique1. L’analyse post-hoc de l’étude NAPOLI 3 a permis de déterminer …

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with ...

26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases Deep and durable responses ongoing for up to 37 weeks through the data cutoff, …

From protocol to empathetic accompaniment: improving dialysis care via psychological education

A groundbreaking shift is happening in the treatment of chronic kidney disease thanks to the work of psychologist Mrs. Erika Danitza Rocabado Vargas. RICHMOND, VA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- With over 19 years of clinical …

NYC Optician French Optical Fashion, Inc. Educates on Eye Wellness

French Optical Fashion, Inc. launches NYC optician campaign to promote eye health with exams and education. NEW YORK, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- French Optical Fashion, Inc., a premier NYC optician located at 7 East …

BREAST CANCER ALLIANCE AWARDS $1.3M IN GRANTS TO ADVANCE RESEARCH, BREAST SURGICAL ONCOLOGY TRAINING, AND ACCESS TO CARE

GREENWICH, CT, CT, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Breast Cancer Alliance (BCA), one of the nation’s leading and most impactful nonprofit breast cancer organizations, proudly announces the awarding of $1.3 million in 2025 grants …

New Book Reveals the Overlooked Toxins Impacting American Homes

A shocking exposé reveals how everyday home materials harm your family—and the proven steps to detox, protect, and rebuild your health. ORLANDO, FL, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- What if the place you trust the most is …

Meaningful Life Counseling Pioneers Early Couples Therapy in CT for Lasting Love

Meaningful Life Counseling in CT promotes early couples therapy to strengthen relationships, offering free consultations to help partners thrive. WOODBRIDGE, CT, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- As couples face mounting …

Mobility City Holdings Inc Celebrates Six Years of Serving People in Lake County Illinois & Surrounding Communities

Kevin Pignone opened his showroom in Grayslake IL with a mission to help people with mobility challenges via the repair, rental and sale of mobility equipment BOCA RATON, FL, US, May 30, 2025 /⁨EINPresswire.com⁩/ -- Mobility City Holdings, Inc., …